More Business Wire
View Older Stories View Newer Stories-
BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
-
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
-
Upbound Group, Inc. Reports Third Quarter 2024 Results
-
ConocoPhillips announces third-quarter 2024 results, increases quarterly ordinary dividend and existing share repurchase authorization
-
Origin Materials Announces Third Quarter 2024 Earnings Release Date and Conference Call
-
Identiv and InPlay Partner for BLE-Enabled IoT Solutions in Cold-Chain, Healthcare, and Automation
-
The Middleby Corporation Reports Third Quarter Results
-
Skillz Announces Change of Date for 2024 Annual Meeting of Stockholders
-
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
-
Dream Finders Announces Third Quarter 2024 Results
-
SLR Credit Solutions Agents Senior Secured Credit Facility to finance the acquisition of portfolio of stores in New York and New Jersey from Rent-A-Center by Directional Capital
-
SunCoke Energy, Inc. Reports Third Quarter 2024 Results
-
Asbury Automotive Group’s Wendy Reynolds-Dobbs is Recognized as an Automotive News Champion of Diversity
-
Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer
-
D-Wave Deemed “Awardable” Vendor for US Department of Defense Chief Digital and Artificial Intelligence Office’s Tradewinds Solutions Marketplace
-
Equillium Maintains Rights to Itolizumab Following Ono Partnership
-
Noridian and HTG Join Forces to Ease the Medicaid Provider Enrollment Experience and Improve Access to Care
-
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
-
Thetis Pharmaceuticals Announces Positive Initial Results From Phase 1a Study of TP-317 in Healthy Subjects
-
Ventus Therapeutics Announces Successful Completion of Phase 1 Clinical Trial of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
-
Largo to Release its Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
BostonGene to Showcase Innovative Precision Medicine Strategies for Non-Small Cell Lung Cancer at the Advancing Precision Medicine Conference 2024
-
Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
-
Xylem Reports Third Quarter 2024 Results and Narrows Full-Year Guidance
-
Uber Announces Results for Third Quarter 2024
-
Green Plains Reports Third Quarter 2024 Financial Results
-
Trinity Industries, Inc. Announces Third Quarter 2024 Results
-
Hyatt Reports Third Quarter 2024 Results
-
Ryder Receives Supplier-of-the-Year Award from Toyota
-
AECOM selected for a $90 million single-award task order for the G7 Partnership for Global Infrastructure and Investment
-
SunCoke Energy, Inc. Declares Cash Dividend
-
Kontoor Brands Reports 2024 Third Quarter Results; Raises Full Year Outlook
-
Green Plains Appoints Phil Boggs as Chief Financial Officer, Jim Stark to Retire From Green Plains
-
Aptiv Reports Third Quarter 2024 Financial Results
-
RPM Acquires TMP Convert to Expand Decking and Landscaping Offerings
-
Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s Progression in 12-month Phase 2 Study, Meeting Primary and Key Secondary Endpoints
-
Granite Reports Third Quarter 2024 Results
-
1-800-FLOWERS.COM, Inc. Reports Fiscal 2025 First Quarter Results
-
Vista Gold Phase 2 Drilling Continues to Intercept High Grade Gold Mineralized Intervals in the South Cross Lode at Mt Todd
-
MarineMax Reports Fiscal 2024 Fourth Quarter and Full Year Results
-
The Estée Lauder Companies Inc. Declares Quarterly Dividend of $.35 Per Share
-
HF Sinclair Corporation Reports 2024 Third Quarter Results and Announces Regular Cash Dividend
-
The Estée Lauder Companies Reports Fiscal 2025 First Quarter Results
-
Eaton Reports Record Third Quarter 2024 Results, with Accelerating Orders and Continued Backlog Growth
-
IDEXX Laboratories Announces Third Quarter Results
-
IDACORP, Inc. Announces Third Quarter 2024 Results, Increases Lower-End of Earnings Guidance Range
-
Mobileye Releases Third Quarter 2024 Results and Provides Business Overview
-
Utz Brands Reports Third Quarter 2024 Results and Reaffirms 2024 Outlook
-
Spectrum Brands Holdings to Report Fiscal 2024 Fourth Quarter Financial Results and Hold Conference Call and Webcast on November 15, 2024
-
Lazard Reports Third-Quarter and Nine-Month 2024 Results
